Nektar Therapeutics (NKTR) Change in Cash (2010 - 2026)

Nektar Therapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at $134.5 million for Q1 2026.

• In Q1 2026, Change in Cash rose 2609.56% year-over-year to $134.5 million; the TTM figure through Mar 2026 stood at $110.7 million (up 1235.45% YoY), while the FY2025 annual figure was -$29.1 million, down 424.64% from the prior year.
• Change in Cash was $134.5 million for Q1 2026 at Nektar Therapeutics, up from -$25.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $134.5 million in Q1 2026 to a low of -$29.6 million in Q4 2023.
• Historically, Change in Cash has averaged $7.3 million across 5 years, with a median of $2.2 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Change in Cash tumbled 374.57% in 2023, then surged 2609.56% in 2026.
• A 5-year view of Change in Cash shows it stood at -$17.5 million in 2022, then plunged by 69.09% to -$29.6 million in 2023, then jumped by 147.71% to $14.1 million in 2024, then tumbled by 283.24% to -$25.9 million in 2025, then surged by 618.84% to $134.5 million in 2026.
• The last three Change in Cash figures came in at $134.5 million (Q1 2026), -$25.9 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.